Select Page

2024

Surgical Planning for Robotic Prostatectomy When You Are Not the First Surgeon to the Site: Access and Salvage Challenges

Surgical Planning for Robotic Prostatectomy When You Are Not the First Surgeon to the Site: Access and Salvage Challenges

Posted by | Aug 2024

John W. Davis, MD, FACS, explores the complexities associated with surgical planning for robotic prostatectomy, particularly when the surgeon is not the first to operate on the site. He underscores the importance of meticulous preoperative planning, which includes thoroughly reviewing the patient’s medical history.

Dr. Davis discusses various challenges that surgeons may encounter, such as scar tissue formation, adhesions, and changes in the pelvic anatomy. He also addresses adapting robotic surgical techniques to accommodate the patient’s altered anatomy.
In addition to access challenges, Dr. Davis delves into the complexities of salvage prostatectomy. Despite these challenges, he stresses that successful outcomes are achievable with proper planning and technique.

Read More
Focal versus Radical – At What Cost

Focal versus Radical – At What Cost

Posted by | Aug 2024

Deepika Reddy, MD, examines the comparative impacts of focal and radical treatments for prostate cancer, focusing on their efficacy, side effects, and overall costs.

Dr. Reddy underscores the growing interest in focal therapies due to their potential to minimize treatment-related side effects; however, Dr. Reddy emphasizes the importance of careful patient selection and thorough pre-treatment imaging to ensure the appropriateness of focal therapy. In contrast, radical treatments provide a comprehensive approach to cancer eradication, offering lower rates of recurrence in appropriately selected patients. These benefits come at the cost of higher rates of adverse effects. Dr. Reddy presents data comparing long-term outcomes of patients undergoing focal versus radical treatments.

Cost considerations also play a crucial role in the treatment decision-making process. Dr. Reddy discusses the direct and indirect costs associated with both approaches.

Read More
Optimizing BPH Clinical Pathway: Navigating the Next 20 Years

Optimizing BPH Clinical Pathway: Navigating the Next 20 Years

Posted by | Aug 2024

Ilya Sobol, MD provides a forward-looking analysis on optimizing the clinical pathway for benign prostatic hyperplasia (BPH) over the next 20 years. He emphasizes the integration of emerging technologies, personalized medicine, and patient-centered care to enhance treatment outcomes and patient satisfaction.

Dr. Sobol discusses the evolving landscape of BPH management, highlighting advances in diagnostic tools, such as improved imaging techniques and biomarker identification, and minimally invasive therapies, such as transurethral water jet ablation and laser enucleation, should be incorporated into standard practice.

Telemedicine and digital health technologies are highlighted as key components of the future clinical pathway. Dr. Sobol envisions the integration of telehealth services for routine follow-ups and monitoring. He also advocates for comprehensive patient education programs that empower individuals to make informed decisions about their care.

Read More

Join the GRU Community

- Why Join? -